Kelley Susan L. 4
4 · Deciphera Pharmaceuticals, Inc. · Filed Jan 20, 2022
Insider Transaction Report
Form 4
Kelley Susan L.
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-01-18$5.22/sh+9,570$49,955→ 9,570 totalExercise: $8.27Exp: 2032-01-17→ Common Stock (9,570 underlying)
Footnotes (1)
- [F1]These options were issued upon election by the director to receive her cash board retainer fee of $50,000 for the FY 2022 in the form of an equity award, in lieu of cash, under the amended and restated non-employee director compensation policy. 2,393 shares will vest on March 31, 2022, 2,393 shares will vest on June 30, 2022, 2,393 shares will vest on September 30, 2022 and the remaining 2,391 shares will vest on December 31, 2022.